相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
Hong Zhang et al.
HEPATOLOGY (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Development of selective androgen receptor modulators (SARMs)
Ramesh Narayanan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer
Hiroki Ide et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy
Nisha M. Badders et al.
NATURE MEDICINE (2018)
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
Kush Dalal et al.
CANCER LETTERS (2018)
Synthesis and evaluation of novel thiazole-based derivatives as selective inhibitors of DNA-binding domain of the androgen receptor
Ruixue Xu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
In vitro metabolism study of a black market product containing SARM LGD-4033
Lore Geldof et al.
DRUG TESTING AND ANALYSIS (2017)
The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications
Haiyan Zhu et al.
ONCOTARGET (2017)
Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer
Minzan Zuo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
Fuqiang Ban et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogova et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma
Qingbo Huang et al.
NATURE COMMUNICATIONS (2017)
Structure of the homodimeric androgen receptor ligand-binding domain
Marta Nadal et al.
NATURE COMMUNICATIONS (2017)
Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells
Hui Ren et al.
ONCOTARGET (2017)
Reproductive Hormones and Their Receptors May Affect Lung Cancer
Mengmeng Dou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor (AR)/miRNA-143-3p signals
Wei Zhai et al.
CELL DEATH AND DIFFERENTIATION (2017)
Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals
Kefeng Wang et al.
CANCER LETTERS (2017)
The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer
Xiangrui Meng et al.
ONCOTARGET (2016)
Antarlides: A New Type of Androgen Receptor (AR) Antagonist that Overcomes Resistance to AR-Targeted Therapy
Shun. Saito et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
Amy E. Monaghan et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells
Paul A. Johnston et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
BA321, a novel carborane analog that binds to androgen and estrogen receptors, acts as a new selective androgen receptor modulator of bone in male mice
Kenta Watanabe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer
Yu Chi Yang et al.
CLINICAL CANCER RESEARCH (2016)
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer
Marcella Bassetto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer
Athanasios Dellis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer
Tongyu Zhu et al.
GENE (2016)
Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling
Mojie Duan et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice
Michael J. Chisamore et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation
Nada Lallous et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2016)
A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data
Hongjuan Zhao et al.
PLOS ONE (2016)
Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression
Fengkun Du et al.
TUMOR BIOLOGY (2016)
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
Jeffrey Crawford et al.
CURRENT ONCOLOGY REPORTS (2016)
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Tatsuo Sugawara et al.
ONCOTARGET (2016)
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression
Guilherme Godoy et al.
BLADDER CANCER (2016)
Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma
Yun-Sok Ha et al.
JOURNAL OF UROLOGY (2015)
Endostatin: A novel inhibitor of androgen receptor function in prostate cancer
Joo Hyoung Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor
Yan Wang et al.
PROSTATE (2015)
Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status
Yuan Chen et al.
ONCOTARGET (2015)
Expression of androgen receptor splice variants in clinical breast cancers
Theresa E. Hickey et al.
ONCOTARGET (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
Anu-Maarit Moilanen et al.
SCIENTIFIC REPORTS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium
Minyoung Lim et al.
ACS CHEMICAL BIOLOGY (2014)
A bufadienolide derived androgen receptor antagonist with inhibitory activities against prostate cancer cells
Hai-Yan Tian et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
Ravi S. N. Munuganti et al.
CHEMISTRY & BIOLOGY (2014)
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
Tiantian Liu et al.
ENDOCRINE-RELATED CANCER (2014)
Androgen receptor antagonists for prostate cancer therapy
Christine Helsen et al.
ENDOCRINE-RELATED CANCER (2014)
Androgen receptor phosphorylation: biological context and functional consequences
Yulia Koryakina et al.
ENDOCRINE-RELATED CANCER (2014)
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif
Katja Jehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
Huifang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)
Fuqiang Ban et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells
Azriel Schmidt et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
C. Chang et al.
ONCOGENE (2014)
The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma
Guodong Zhu et al.
UROLOGY (2014)
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines
Pietro Rizza et al.
BREAST CANCER RESEARCH (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
D. Bianchini et al.
BRITISH JOURNAL OF CANCER (2013)
Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
Yangmin M. Ning et al.
CLINICAL CANCER RESEARCH (2013)
Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
Nada Lallous et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Identification of Novel Androgen Receptor Antagonists Using Structure- and Ligand-Based Methods
Huifang Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives
Ravi Shashi Nayana Munuganti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men
Shehzad Basaria et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Ayesha A. Shafi et al.
PHARMACOLOGY & THERAPEUTICS (2013)
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Nicola J. Clegg et al.
CANCER RESEARCH (2012)
Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
Won Kim et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist
Chin-Hee Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
True Antiandrogens-Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor-Coactivator Interactions: Novel Tools for Prostate Cancer
Laura Caboni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
Masaki Shiota et al.
JOURNAL OF UROLOGY (2012)
The hinge region in androgen receptor control
Liesbeth Clinckemalie et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth
Christine Helsen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A refined molecular taxonomy of breast cancer
M. Guedj et al.
ONCOGENE (2012)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
Peter Axerio-Cilies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening
Nathan A. Lack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Reduced Expression of the Androgen Receptor by Third Generation of Antisense Shows Antitumor Activity in Models of Prostate Cancer
Yixian Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer
Dionysis Papadatos-Pastos et al.
ONCOLOGIST (2011)
Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer
Martin Ligr et al.
PLOS ONE (2011)
Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
Johanny Tonos De Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140
Chris P. Miller et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
Francesca De Amicis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
A (RKLKK633)-R-629 motif in the hinge region controls the androgen receptor at multiple levels
Tamzin M. Tanner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Hormone treatment and muscle anabolism during aging: Androgens
E. Lichar Dillon et al.
CLINICAL NUTRITION (2010)
Design and Synthesis of Androgen Receptor Full Antagonists Bearing a p-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome
Tokuhito Goto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Alternative Inhibition of Androgen Receptor Signaling: Peptidomimetic Pyrimidines As Direct Androgen Receptor/Coactivator Disruptors
Jillian R. Gunther et al.
ACS CHEMICAL BIOLOGY (2009)
Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation
Robert D. Ward et al.
BIOFACTORS (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Amelia A. Peters et al.
CANCER RESEARCH (2009)
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists
James D. Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Non-competitive androgen receptor inhibition in vitro and in vivo
Jeremy O. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A cellular conformation-based screen for androgen receptor inhibitors
Jeremy O. Jones et al.
ACS CHEMICAL BIOLOGY (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
A multifunctional androgen receptor screening assay using the high-throughput HyperCyt® flow cytometry system
Megan K. Dennis et al.
CYTOMETRY PART A (2008)
A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions
A. Deeb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside
Toru Furukawa
JOURNAL OF GASTROENTEROLOGY (2008)
Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain
Philippa Davies et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Sintokamides A to E, Chlorinated Peptides from the Sponge Dysidea sp that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
Marianne D. Sadar et al.
ORGANIC LETTERS (2008)
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission
Douglas Levine et al.
CANCER (2007)
Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12
Line Cantin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Selective role of an NH2-Terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion-independent prostate cancer cells
Scott M. Dehm et al.
CANCER RESEARCH (2007)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Androgen receptor blockade in experimental combination therapy of pancreatic cancer
Srivani Konduri et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy
Doris Germain et al.
CLINICAL CANCER RESEARCH (2007)
The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor
Annemie Haelens et al.
CANCER RESEARCH (2007)
Androgen receptor decoy molecules block the growth of prostate cancer
Steven N. Quayle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Wenqing Gao et al.
DRUG DISCOVERY TODAY (2007)
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: Glucocorticoid, mineralocorticoid, progesterone, and androgen receptors
Nick Z. Lu et al.
PHARMACOLOGICAL REVIEWS (2006)
Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?
Kyung W. Noh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial
SS Negi et al.
INVESTIGATIONAL NEW DRUGS (2006)
A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin
JW Li et al.
MOLECULAR ENDOCRINOLOGY (2006)
Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen™ cells
N Araki et al.
TOXICOLOGY IN VITRO (2005)
The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions
F Schaufele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chemistry and structural biology of androgen receptor
WQ Gao et al.
CHEMICAL REVIEWS (2005)
Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells
N Blaszczyk et al.
CLINICAL CANCER RESEARCH (2004)
Recognition and accommodation at the androgen receptor coactivator binding interface
E Hur et al.
PLOS BIOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
J Edwards et al.
BRITISH JOURNAL OF CANCER (2003)
Androgen receptor mutations and androgen insensitivity
MJ McPhaul
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
P Corrie et al.
BRITISH JOURNAL OF CANCER (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations
PM Matias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
B He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects
B Térouanne et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
分享论文
